Home > Firm Summary

Grant Thornton AG Wirtschaftsprüfungsgesellschaft (5772)
Registration Status: Currently Registered
Headquarters Address: Johannstrasse 39, Düsseldorf, NRW 40476
Other Names Used in Issuing Audit Reports: None
Predecessor Firm to Whose Registration
the Firm Succeeded:
None
Registration Date: 03/26/2013
For a list of issuers (if any) that the firm has audited, or in whose audits the firm has played a substantial role, see Part IV of the firm's annual reports.

Annual and Special Reporting by the Firm
FormFiled DateSpecial Report Relates To
Special Report (Form 3) 09/26/2023 Changes in the Firm or the Firm's Board Contact Person
Annual Report (Form 2) For Reporting Year 2023 06/26/2023
Special Report (Form 3) 03/01/2023 Licenses and Certification
Annual Report (Form 2) For Reporting Year 2022 06/23/2022
Special Report (Form 3) 03/08/2022 Changes in the Firm or the Firm's Board Contact Person
Annual Report (Form 2) For Reporting Year 2021 06/18/2021
Annual Report (Form 2) For Reporting Year 2020 06/09/2020
Special Report (Form 3) 12/04/2019 Changes in the Firm or the Firm's Board Contact Person
Annual Report (Form 2) For Reporting Year 2019 06/19/2019
Annual Report (Form 2) For Reporting Year 2018 06/25/2018
Annual Report (Form 2) For Reporting Year 2017 06/26/2017
Annual Report (Form 2) For Reporting Year 2016 06/21/2016
Special Report (Form 3) 04/12/2016 Changes in the Firm or the Firm's Board Contact Person
Special Report (Form 3) 09/28/2015 Changes in the Firm or the Firm's Board Contact Person
Annual Report (Form 2) For Reporting Year 2015 06/25/2015
Annual Report (Form 2) For Reporting Year 2014 06/27/2014
Annual Report (Form 2) For Reporting Year 2013 06/26/2013

Auditor Reporting of Certain Audit Participants
FormFiled DateIssuer NameAudit Report DateEngagement Partner
Form AP 04/29/2021 Biofrontera AG 04/12/2021 Meyer zu Schwabedissen, Maximilian
Form AP 05/20/2020 Biofrontera AG 04/20/2020 Dr. Senger, Thomas
Form AP 05/24/2019 Biofrontera AG 04/25/2019 Dr. Senger, Thomas
Form AP 05/22/2018 Biofrontera AG 04/25/2018 Dr. Senger, Thomas
Form AP 01/18/2018 Biofrontera AG 10/04/2017 Dr. Senger, Thomas